Clover Health Investments EBITDA Margin 2020-2026 | CLOV
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Clover Health Investments (CLOV) over the last 10 years. The current EBITDA margin for Clover Health Investments as of June 30, 2026 is .
| Clover Health Investments EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2026-06-30 | $2.48B | $-0.02B | -0.73% |
| 2026-03-31 | $2.21B | $-0.06B | -2.58% |
| 2025-12-31 | $1.93B | $-0.09B | -4.42% |
| 2025-09-30 | $1.77B | $-0.06B | -3.21% |
| 2025-06-30 | $1.61B | $-0.04B | -2.61% |
| 2025-03-31 | $1.49B | $-0.02B | -1.62% |
| 2024-12-31 | $1.37B | $-0.05B | -3.36% |
| 2024-09-30 | $1.35B | $-0.09B | -6.54% |
| 2024-06-30 | $1.32B | $-0.11B | -8.55% |
| 2024-03-31 | $1.29B | $-0.15B | -11.36% |
| 2023-12-31 | $1.26B | $-0.21B | -16.35% |
| 2023-09-30 | $-0.53B | $-0.17B | 31.33% |
| 2023-06-30 | $0.02B | $-0.21B | -1150.00% |
| 2023-03-31 | $0.55B | $-0.28B | -51.93% |
| 2022-12-31 | $1.10B | $-0.29B | -26.16% |
| 2022-09-30 | $3.01B | $-0.45B | -14.92% |
| 2022-06-30 | $2.58B | $-0.52B | -20.31% |
| 2022-03-31 | $2.15B | $-0.60B | -28.16% |
| 2021-12-31 | $1.47B | $-0.62B | -42.28% |
| 2021-09-30 | $1.21B | $-0.50B | -41.24% |
| 2021-06-30 | $0.95B | $-0.37B | -38.54% |
| 2021-03-31 | $0.71B | $-0.16B | -21.92% |
| 2020-12-31 | $0.67B | $-0.07B | -10.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.422B | $1.924B |
| Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $42.890B | 42.79 |
| Tempus AI (TEM) | United States | $12.625B | 0.00 |
| 10x Genomics (TXG) | United States | $9.470B | 0.00 |
| Hinge Health (HNGE) | United States | $7.563B | 72.66 |
| Hims & Hers Health (HIMS) | United States | $6.533B | 0.00 |
| Doximity (DOCS) | United States | $4.624B | 28.50 |
| Heartflow (HTFL) | United States | $4.200B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.686B | 243.09 |
| Privia Health (PRVA) | United States | $2.602B | 97.00 |
| Inspire Medical Systems (INSP) | United States | $2.103B | 32.05 |
| Butterfly Network (BFLY) | United States | $1.933B | 0.00 |
| Schrodinger (SDGR) | United States | $1.767B | 0.00 |
| Omnicell (OMCL) | United States | $1.475B | 21.06 |
| Azenta (AZTA) | United States | $1.455B | 79.07 |
| Enovis (ENOV) | United States | $1.076B | 5.57 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.669B | 0.00 |
| Phreesia (PHR) | United States | $0.636B | 34.13 |
| Veradigm (MDRX) | United States | $0.597B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Claritev (CTEV) | United States | $0.569B | 0.00 |
| Evolent Health (EVH) | United States | $0.423B | 0.00 |
| Carlsmed (CARL) | United States | $0.418B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.379B | 0.00 |
| CapsoVision (CV) | United States | $0.300B | 0.00 |
| Standard BioTools (LAB) | United States | $0.278B | 0.00 |
| American Well (AMWL) | United States | $0.221B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.147B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.117B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.084B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.063B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.055B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.048B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.034B | 0.00 |
| 111 (YI) | China | $0.030B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.025B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.019B | 0.00 |
| HeartSciences (HSCS) | United States | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |